CY1108250T1 - Διαδερμικο θεραπευτικο συστημα για τη χορηγηση μη στεροειδικων αντιφλογιστικων που φερουν καρβοξυλομαδες, καθως και μεθοδος για την παραγωγη του - Google Patents
Διαδερμικο θεραπευτικο συστημα για τη χορηγηση μη στεροειδικων αντιφλογιστικων που φερουν καρβοξυλομαδες, καθως και μεθοδος για την παραγωγη τουInfo
- Publication number
- CY1108250T1 CY1108250T1 CY20081100839T CY081100839T CY1108250T1 CY 1108250 T1 CY1108250 T1 CY 1108250T1 CY 20081100839 T CY20081100839 T CY 20081100839T CY 081100839 T CY081100839 T CY 081100839T CY 1108250 T1 CY1108250 T1 CY 1108250T1
- Authority
- CY
- Cyprus
- Prior art keywords
- therapeutic system
- carboxyl groups
- interderative
- antiflogists
- carboxylamides
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 3
- 239000010410 layer Substances 0.000 abstract 3
- 239000011159 matrix material Substances 0.000 abstract 3
- 239000013543 active substance Substances 0.000 abstract 2
- 229910001414 potassium ion Inorganic materials 0.000 abstract 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 abstract 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 abstract 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 abstract 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 abstract 1
- 239000005642 Oleic acid Substances 0.000 abstract 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 230000003356 anti-rheumatic effect Effects 0.000 abstract 1
- 239000003435 antirheumatic agent Substances 0.000 abstract 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 abstract 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 abstract 1
- 239000011241 protective layer Substances 0.000 abstract 1
- 230000003637 steroidlike Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Abstract
Διαδερμικό θεραπευτικό σύστημα (TTS) με περιεχόμενο τουλάχιστον μίας δραστικής ουσίας από την ομάδα των μη στερεοειδικών αντιρευματικών που φέρουν καρβοξυλομάδες, το οποίο περιλαμβάνει οπίσθια στιβάδα (1), στιβάδα μήτρας που περιέχει δραστική ουσία (2) καθώς και αποσπώμενη προστατευτική στιβάδα (3), χαρακτηρίζεται από στιβάδα μήτρας (2) βασιζόμενη σε πολυακρυλικό συγκολλητικό πίεσης που φέρει καρβοξυλομάδες, η οποία εμφανίζει περιεχόμενο ελαϊκού οξέος και περιεχόμενο ιόντων καλίου, όπου το εκατοστιαίο ποσοστό των ιόντων καλίου είναι στο εύρος 5 εως 50%, σε σχέση με το ισοδύναμο βάρος του αθροίσματος όλων των συστατικών μήτρας που φέρουν καρβοξυλομάδες.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10103860A DE10103860B4 (de) | 2001-01-30 | 2001-01-30 | Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung |
EP02715442A EP1355636B1 (de) | 2001-01-30 | 2002-01-17 | Transdermales therapeutisches system für die verabreichung carboxylgruppenhaltiger, nichtsteroidaler antiphlogistika, sowie verfahren zu seiner herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1108250T1 true CY1108250T1 (el) | 2014-02-12 |
Family
ID=7672050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20081100839T CY1108250T1 (el) | 2001-01-30 | 2008-08-11 | Διαδερμικο θεραπευτικο συστημα για τη χορηγηση μη στεροειδικων αντιφλογιστικων που φερουν καρβοξυλομαδες, καθως και μεθοδος για την παραγωγη του |
Country Status (11)
Country | Link |
---|---|
US (1) | US7332180B2 (el) |
EP (1) | EP1355636B1 (el) |
JP (1) | JP4160394B2 (el) |
KR (1) | KR100822418B1 (el) |
AT (1) | ATE395050T1 (el) |
CY (1) | CY1108250T1 (el) |
DE (2) | DE10103860B4 (el) |
DK (1) | DK1355636T3 (el) |
ES (1) | ES2307737T3 (el) |
PT (1) | PT1355636E (el) |
WO (1) | WO2002060418A1 (el) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10102817B4 (de) * | 2001-01-23 | 2006-01-12 | Lts Lohmann Therapie-Systeme Ag | Vorrichtung und Verfahren zur Hitzepulsgestützten transdermalen Applikation von Wirkstoffen |
DE10159745A1 (de) | 2001-12-05 | 2003-07-03 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort |
US8133505B2 (en) | 2002-10-31 | 2012-03-13 | Transpharma Medical Ltd. | Transdermal delivery system for dried particulate or lyophilized medications |
IL152574A (en) * | 2002-10-31 | 2009-09-22 | Transpharma Medical Ltd | A system for passing through the skin of dry items or dried medicines |
US20050137262A1 (en) * | 2003-12-22 | 2005-06-23 | Hu Patrick C. | Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses |
DE102004039728A1 (de) * | 2004-08-16 | 2006-02-23 | Beiersdorf Ag | Wirkstoffhaltiges Tape zur Behandlung von Gelenkerkrankungen |
KR100663163B1 (ko) | 2005-10-24 | 2007-01-02 | (주)아모레퍼시픽 | 비스테로이드성 소염진통제를 함유하는 경피 투여 제제 |
TWI389709B (zh) | 2005-12-01 | 2013-03-21 | Novartis Ag | 經皮治療系統 |
DE102006054733A1 (de) * | 2006-11-21 | 2008-05-29 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit |
JP5209433B2 (ja) * | 2007-10-19 | 2013-06-12 | 日東電工株式会社 | 貼付製剤 |
WO2011129269A1 (ja) * | 2010-04-13 | 2011-10-20 | 東亞合成株式会社 | 医療用粘着剤組成物、医療用貼付剤及び該組成物の製造方法 |
EP2468274B1 (de) * | 2010-12-14 | 2015-07-01 | Acino AG | Transdermales therapeutisches System zur Verabreichung eines Wirkstoffs |
DE102011114411A1 (de) * | 2011-09-26 | 2013-03-28 | Lts Lohmann Therapie-Systeme Ag | Pflaster mit einstellbarer Okklusion |
WO2014159798A1 (en) | 2013-03-13 | 2014-10-02 | Avery Dennison Corporation | Improving adhesive properties |
DE102014007650A1 (de) | 2013-05-24 | 2014-11-27 | Amw Gmbh | Pflaster mit bielastischer Rückschicht |
US20170136124A1 (en) * | 2015-11-16 | 2017-05-18 | Noven Pharmaceuticals, Inc. | Stretchable backing layers for transdermal drug delivery systems |
CN109862885A (zh) * | 2016-10-18 | 2019-06-07 | Lts勒曼治疗系统股份公司 | 双层局部治疗系统 |
WO2019068288A1 (de) | 2017-10-04 | 2019-04-11 | Berlimed International Research Gmbh | Wirkstoff und wirkstoffmatrix enthaltendes produkt zur transdermalen wirkstoffabgabe sowie dessen herstellung und verwendung sowie die wirkstoffmatrix, ihre herstellung und verwendung |
DE102021128911A1 (de) | 2021-11-05 | 2023-05-11 | Lts Lohmann Therapie-Systeme Ag. | Diclofenac enthaltendes tts mit dimethylpropylenharnstoff |
DE102021128912A1 (de) | 2021-11-05 | 2023-05-11 | Lts Lohmann Therapie-Systeme Ag. | Okklusives pflaster mit flexibler backing |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3046346B2 (ja) * | 1990-03-12 | 2000-05-29 | 昭和電工株式会社 | 外用剤基剤又は補助剤とそれを含有する人又は動物の外用剤 |
DE4020144A1 (de) * | 1990-06-25 | 1992-01-09 | Lohmann Therapie Syst Lts | Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen |
JPH0474113A (ja) * | 1990-07-13 | 1992-03-09 | Kao Corp | 染毛剤組成物 |
JP3046330B2 (ja) * | 1990-07-16 | 2000-05-29 | 日東電工株式会社 | 貼付製剤 |
US5125995A (en) | 1990-09-10 | 1992-06-30 | Minnesota Mining And Manufacturing Company | Method of using a water-dispersible pressure sensitive adhesive tape on cloth body coverings |
US5906830A (en) * | 1995-09-08 | 1999-05-25 | Cygnus, Inc. | Supersaturated transdermal drug delivery systems, and methods for manufacturing the same |
DE19706824C1 (de) * | 1997-02-21 | 1998-03-26 | Lohmann Therapie Syst Lts | Transdermales oder topisches Plastersystem mit Polyacrylatmatrix mit verbesserten physikalischen Eigenschaften |
DE19814083C2 (de) * | 1998-03-30 | 2002-02-07 | Lohmann Therapie Syst Lts | Verfahren zur Herstellung von transdermalen therapeutischen Systemen unter Verwendung von basischen Alkalimetallsalzen zur Umwandlung von Wirkstoffsalzen in die freien Basen |
JP4275768B2 (ja) * | 1998-06-18 | 2009-06-10 | 久光製薬株式会社 | 水性粘着膏体 |
DE19830649C2 (de) * | 1998-07-09 | 2003-04-10 | Lohmann Therapie Syst Lts | Topisches Pflaster mit nichtsteroidalen Antirheumatika mit Säuregruppe |
DE19918106A1 (de) * | 1999-04-22 | 2000-10-26 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern |
-
2001
- 2001-01-30 DE DE10103860A patent/DE10103860B4/de not_active Expired - Fee Related
-
2002
- 2002-01-17 DK DK02715442T patent/DK1355636T3/da active
- 2002-01-17 JP JP2002560611A patent/JP4160394B2/ja not_active Expired - Lifetime
- 2002-01-17 US US10/470,701 patent/US7332180B2/en not_active Expired - Lifetime
- 2002-01-17 WO PCT/EP2002/000417 patent/WO2002060418A1/de active IP Right Grant
- 2002-01-17 PT PT02715442T patent/PT1355636E/pt unknown
- 2002-01-17 AT AT02715442T patent/ATE395050T1/de active
- 2002-01-17 EP EP02715442A patent/EP1355636B1/de not_active Expired - Lifetime
- 2002-01-17 DE DE50212267T patent/DE50212267D1/de not_active Expired - Lifetime
- 2002-01-17 KR KR1020037009972A patent/KR100822418B1/ko active IP Right Grant
- 2002-01-17 ES ES02715442T patent/ES2307737T3/es not_active Expired - Lifetime
-
2008
- 2008-08-11 CY CY20081100839T patent/CY1108250T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR100822418B1 (ko) | 2008-04-16 |
DE10103860B4 (de) | 2004-12-23 |
US20040071764A1 (en) | 2004-04-15 |
US7332180B2 (en) | 2008-02-19 |
KR20030072609A (ko) | 2003-09-15 |
DE50212267D1 (de) | 2008-06-26 |
DE10103860A1 (de) | 2002-08-14 |
EP1355636A1 (de) | 2003-10-29 |
EP1355636B1 (de) | 2008-05-14 |
ES2307737T3 (es) | 2008-12-01 |
JP4160394B2 (ja) | 2008-10-01 |
PT1355636E (pt) | 2008-08-25 |
JP2004516916A (ja) | 2004-06-10 |
WO2002060418A1 (de) | 2002-08-08 |
DK1355636T3 (da) | 2008-09-08 |
ATE395050T1 (de) | 2008-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1108250T1 (el) | Διαδερμικο θεραπευτικο συστημα για τη χορηγηση μη στεροειδικων αντιφλογιστικων που φερουν καρβοξυλομαδες, καθως και μεθοδος για την παραγωγη του | |
CY1105138T1 (el) | Θepμου-τηγματος-δθς για χορηγηση ροτιγκοτινης | |
CY1106411T1 (el) | Διαδepμικο θepαπευτικο συστημα με fentanyl | |
CY1105878T1 (el) | Βελτιωμενο συστημα διαδepμικης χορηγησης | |
NO20050472L (no) | Forbedret transdermalt leveringssystem for administrering av rotigotin | |
AR097045A2 (es) | Sistema terapéutico transdérmico | |
DK0973497T3 (da) | Farmaceutisk bæreanordning, egnet til udlevering af farmaceutiske forbindelser til slimhindeoverflade | |
HUP0103715A2 (hu) | Topikus tapasz savcsoportot tartalmazó nemszteroid reumaellenes hatóanyaggal | |
ES2167116T3 (es) | Sistema terapeutico transdermico (tts) que contiene pergolida. | |
SV2004001556A (es) | Preparaciones acidas de insulina con establidad mejorada | |
NO307644B1 (no) | Transdermalt, terapeutisk system med krystalliseringsinhibitor | |
DK1009393T3 (da) | Transdermalt, terapeutisk system med hæfteklæbende reservoirlag og bagsidelag, som er elastisk i én retning | |
ATE526038T1 (de) | Implantierbares medizinprodukt mit kontinuierlichem mittel-konzentrationsgefälle | |
AR050621A1 (es) | Sistema terapeutico transdermal con una capa adherente procedimiento para el siliconado de una capa de respaldo y empleo de la capa de respaldo | |
DE60114635D1 (de) | Pharmazeutische formulierungen | |
CY1116111T1 (el) | Τοπικη συνθεση για τη θεραπεια της ακτινικης κερατωσης | |
AR043248A1 (es) | Sistema terapeutico transdermico estable a los rayos uv | |
AR054012A1 (es) | Sistema terapeutico transdermico para la adminstracion de analgesicos | |
PT1191927E (pt) | Sistema de microrreservatorios a base de polissiloxanos e solventes ambifilicos | |
ES2165232T3 (es) | Sistema terapeutico transdermico (tts) que contiene oxibutinina. | |
FI950165A (fi) | Ihon läpäisevä terapeuttinen järjestelmä, jossa vaikuttavana aineena on 17-beta-estradioli (vedetön) | |
ATE367154T1 (de) | Transdermales therapeutisches system mit einer selbstklebenden matrix, enthaltend organische säure-additionssalze von alkaloiden des morphin- bzw. morphinantyps | |
AR028525A1 (es) | Sistema terapeutico transdermal para la administracion de lerisetron | |
CY1115757T1 (el) | Στερεο διαδερμικο θεραπευτικο συστημα που περιλαμβανει uv-απορροφητη | |
YU3390A (sh) | Postupak za izradu površinskog terapijskog sistema sa sadržajem antineoplastične aktivne materije, naročito 5-fluor-uracila |